FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
Treatment with TSND-201 was associated with statistically significant improvement in PTSD symptoms. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 ...
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.
Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough therapy designation to veligrotug. Veligrotug demonstrated rapid reduction and ...
A revolutionary treatment brings new hope to those suffering from a devastating rare skin disorder, while showcasing an innovative funding model that could transform rare disease research In a ...